SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001654954-22-016633
Filing Date
2022-12-16
Accepted
2022-12-16 16:14:11
Documents
75
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-K edsa_10k.htm   iXBRL 10-K 1322627
2 THIRD AMENDMENT TO EXCLUSIVE LICENSE AGREEMENT edsa_ex1011.htm EX-10.11 24676
3 CONSENT OF MNP LLP edsa_ex231.htm EX-23.1 2108
4 CERTIFICATION edsa_ex311.htm EX-31.1 11552
5 CERTIFICATION edsa_ex312.htm EX-31.2 9123
6 CERTIFICATION edsa_ex321.htm EX-32.1 4452
7 CERTIFICATION edsa_ex322.htm EX-31.2 3487
  Complete submission text file 0001654954-22-016633.txt   5314665

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA edsa-20220930.xsd EX-101.SCH 62032
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE edsa-20220930_lab.xml EX-101.LAB 316456
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE edsa-20220930_cal.xml EX-101.CAL 39830
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE edsa-20220930_pre.xml EX-101.PRE 264631
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE edsa-20220930_def.xml EX-101.DEF 134615
69 EXTRACTED XBRL INSTANCE DOCUMENT edsa_10k_htm.xml XML 748451
Mailing Address 100 SPY COURT MARKHAM A6 L3R 5H6
Business Address 100 SPY COURT MARKHAM A6 L3R 5H6 (905) 475-1234
Edesa Biotech, Inc. (Filer) CIK: 0001540159 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-37619 | Film No.: 221468103
SIC: 2834 Pharmaceutical Preparations